SCHEMBL25663153

SCHEMBL25663153

c1ccc2nc(-c3ccc(N(c4ccc(-c5cnc6ccccc6n5)cc4)c4ccc5cc(-c6ncnc7c6sc6ccccc67)ccc5c4)cc3)cnc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LIMK1 P53667 3/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ RAB9A P51151 5/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ BCHE P06276 1/20 0.36
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ PIK3CA P42336 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663151 0.90 LIMK1 (0.35) NPC1LIMK1CDK5CDK5R1RAB9A
SCHEMBL25663158 0.87 LIMK1 (0.37) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663152 0.86 CYP1A2 (0.42) NPC1MAPTLIMK1CDK5CDK5R1
SCHEMBL25663156 0.85 MAP4K4 (0.37) NPC1LIMK1CDK5CDK5R1RAB9A
SCHEMBL25663155 0.85 LIMK1 (0.35) NPC1LIMK1CDK5CDK5R1RAB9A
SCHEMBL25663489 0.84 LIMK1 (0.35) NPC1LIMK1CDK5CDK5R1RAB9A
SCHEMBL25663159 0.83 NPC1 (0.35) NPC1LIMK1CDK5CDK5R1RAB9A
SCHEMBL25663157 0.83 LIMK1 (0.35) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663149 0.82 LIMK1 (0.40) LIMK1CDK5CDK5R1HTR2CHRH4
SCHEMBL25663154 0.81 LIMK1 (0.36) LIMK1CDK5CDK5R1HTR2CHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 NPC1 3859/4885MAPT 4606/4885KDM4E 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback